FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling

FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim